Focus Partners Wealth’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.31M Sell
16,987
-3,946
-19% -$818K ﹤0.01% 1134
2026
Q1
$4.7M Buy
20,933
+5,183
+33% +$1.29M 0.01% 958
2025
Q4
$3.79M Buy
15,750
+5,543
+54% +$1.42M ﹤0.01% 1052
2025
Q3
$2.79M Sell
10,207
-505
-5% -$138K ﹤0.01% 918
2025
Q2
$2.76M Sell
10,712
-704
-6% -$168K 0.01% 820
2025
Q1
$2.56M Sell
11,416
-195
-2% -$45.5K 0.01% 787
2024
Q4
$2.66M Buy
11,611
+7,703
+197% +$1.85M 0.01% 778
2024
Q3
$954K Sell
3,908
-734
-16% -$164K ﹤0.01% 956
2024
Q2
$888K Buy
+4,642
New +$942K ﹤0.01% 820

Other funds holding RMD

Focus Partners Wealth's RMD Position: Q2 2026 in Review

Focus Partners Wealth reduced its ResMed (RMD) stake by 19% in Q2 2026, selling an estimated $818K and leaving 16,987 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

Focus Partners Wealth first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.7M in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Focus Partners Wealth held 16,987 shares of ResMed worth $3.31M as of Q2 2026.
  • Focus Partners Wealth sold 3,946 ResMed shares in Q2 2026, an estimated $818K.
  • ResMed made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #1134 holding.
  • Focus Partners Wealth first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • Focus Partners Wealth's ResMed position peaked at $4.7M in Q1 2026.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.